GGrantIndex
← Leaderboards

Kennesaw State University

Kennesaw, GA

Compare ↔
$32,435,879
Total funding
65
Grants

Funding over time

peak $5.1M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,268,969 · 47
NSF$2,845,070 · 15
DOD$2,088,090 · 1
DOE$233,750 · 2

By mechanism

R15$12,568,582 · 28
R01$7,775,691 · 5
—$5,166,910 · 18
R25$1,627,007 · 2
R16$1,416,500 · 4
R21$955,458 · 3

Investigators at Kennesaw State University

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Christina Scherrer$782,5132 gr2Geza Frank Kogler$608,3921 gr3Seung Yup Lee$579,0611 gr4Mohammad Halim$529,3591 gr5Lei Shi$522,6951 gr6Robert Buresh$428,1911 gr7Amir Ali Amiri Moghadam$364,2201 gr8Vishnu Suppiramaniam$301,3501 gr

Emerging Leaders

6–10 yrs in

1Evelina Sterling$696,4581 gr2Katherine Heimburger Ingram$606,9811 gr3Daniel P Morris$403,8001 gr4Brian Kliszczewicz$380,4051 gr

All-Time

Most funded here, all years

1Patricia Hodapp Reggio$6,520,0564 gr2Monica H Swahn$2,916,3422 gr3Martin Lyn Hudson$1,351,2883 gr4Miriam W Boeri$954,3203 gr5Scott James Nowak$851,9772 gr6Carol Ann Chrestensen$801,0272 gr7Christina Scherrer$782,5132 gr8Evelina Sterling$696,4581 gr

Largest grants

VALIDATION OF AMPA RECEPTOR PEPTIDE ASSAY TO IMPROVE DIANOSTIC CERTAINTY OF MTBI$2,088,090
· FY2011 · Department of Defense
CyberTech Computer Science Program to Prepare Underrepresented Students for Careers in the Sciences$1,030,714
· FY2004 · EDU
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$688,344
R01 · FY2021 · AI
TOPOWA Study: Social Drivers of Mental Illness among AGYW in Slums.$682,116
R01 · FY2022 · MH
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$681,374
R01 · FY2022 · AI
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$675,005
R01 · FY2023 · AI
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$673,815
R01 · FY2024 · AI
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug$666,604
R01 · FY2025 · AI
TOPOWA Study: Social Drivers of Mental Illness among AGYW in Slums.$654,398
R01 · FY2023 · MH
TOPOWA Study: Social Drivers of Mental Illness among AGYW in Slums.$652,065
R01 · FY2024 · MH
TOPOWA Study: Social Drivers of Mental Illness among AGYW in Slums.$545,646
R01 · FY2025 · MH
The role of homeobox transcription factor Nkx2.1 in nervous system development$539,999
R15 · FY2025 · NS
Developing Next Generation Eutectic Solvents for Biomedical Applications$529,359
R15 · FY2025 · GM
Integrating Generative AI with Biomechanics Modeling to Advance Ventricular Disease Diagnosis and Personalized Treatment$522,695
R15 · FY2025 · HL
Developmental regulation of epithelial cell$447,601
R15 · FY2023 · GM
Elucidating the mechanisms by which ectopically expressed genes and piRNAs perturb somatic cell function when histone methylation is inappropriately regulated$432,000
R15 · FY2023 · GM
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults$428,191
R15 · FY2024 · AG
Affordable Shortwave Infrared Spectroscopy for Stroke Risk Screening in Children with Sickle Cell Disease$426,714
R15 · FY2023 · EB
Removing Barriers to Fluoride Varnish Application in Primary Care Settings$423,574
R15 · FY2022 · DE
Cell-penetrating peptide adaptors for intracellular cargo delivery$406,500
R15 · FY2023 · EB